Kelsey Poorman - Concepedia

Author

Kelsey Poorman

Caris Life Sciences (United States)

Also Known As

K Poorman, K. Poorman, Kelsey A. Poorman, Kelsey Anne Poorman, Kelsey Poorman, Motsinger-Reif, Alison

Publications

891

Citations

H-Index

Concepts

All Affiliations

Caris Life Sciences (United States)The Barbara Ann Karmanos Cancer Institute Georgetown University Georgetown University Medical Center Levine Cancer Institute

About

Kelsey Poorman is an author at Caris Life Sciences (United States) specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	329
2	Pathology	5	5	329
3	Cell Biology	2	2	117
4	Public Health	1	1	115
5	Molecular Medicine	1	1	42

Kelsey Poorman

Publications

828

Citations

H-Index

Page 1

	Year	Citations
Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets Benjamin A. Weinberg, Joanne Xiu, Michael Lindberg, Journal of Gastrointestinal Oncology	2019	175
Prevalence of class I–III BRAF mutations among 114,662 cancer patients in a large genomic database Jeff Owsley, Matthew K. Stein, Jason Porter, Experimental Biology and Medicine Class IiGeneticsGenetic EpidemiologyPathologyCancer Patients	2020	115
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) Alberto Puccini, Kelsey Poorman, Mohamed E. Salem, Clinical Cancer Research	2020	101
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis William P.D. Hendricks, Victoria Zismann, Karthigayini Sivaprakasam, PLoS Genetics Canine MelanomaSomatic VariantHuman MelanomaMelanomaPathology	2018	69
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers Kabir Mody, Jason S. Starr, Michelle Saul, Journal of Gastrointestinal Oncology	2019	66
Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization Kelsey Poorman, Luke B. Borst, Scott Moroff, Chromosome Research Array CghMelanomaHistopathologyPathologyComparative Cytogenetic Characterization	2014	55
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors Alberto Puccini, Heinz‐Josef Lenz, John L. Marshall, The Oncologist	2018	54
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets Alberto Puccini, Kelsey Poorman, Fabio Catalano, Oncogene Tumor BiologyOncologyGastrointestinal OncologySignet-ring-cell CarcinomaMedicine	2022	48
Comparison of the biomarkers for targeted therapies in primary extra‐mammary and mammary Paget's disease Zoran Gatalica, Semir Vranić, Božo Krušlin, Cancer Medicine	2020	44
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial Aaron S. Mansfield, Zihan Wei, Ranee Mehra, npj Precision Oncology Nci-match TrialOncologyMedicinePathologySub-protocols F	2022	42

Page 1